Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes

Leukemia

Volumn 22, Issue 3, 2008, Pages 530-537

  Della Porta, M G ^a   Malcovati, L ^a   Rigolin, G M ^b   Rosti, V ^a   Bonetti, E ^a   Travaglino, E ^a   Boveri, E ^a   Galli A ^a   Boggi, S ^a   Ciccone, M ^b   Pramparo, T ^a   Mazzini, G ^c   Invernizzi, R ^a   Lazzarino, M ^a   Cazzola, M ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW; CELL INTERACTION; CELL MATURATION; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; COLONY FORMING CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; STEM CELL; TUMOR VASCULARIZATION;

EID: 40749108516     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2405069     Document Type: Article

References (37)

1. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653-660.
2. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-257.
3. Streubel B, Chott A, Huber D, Exner M, Jager U, Wagner O et al. Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N Engl J Med 2004; 351: 250-259.
4. Peters BA, Diaz LA, Polyak K, Meszler L, Romans K, Guinan EC et al Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 2005; 11: 261-262.
5. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001; 7: 1194-1201.
6. Mancuso P, Burlini A, Pruneri G, Goldhirsch A, Martinelli G, Bertolini F. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 2001; 97: 3658-3661.
7. Beerepoot LV, Mehra N, Vermaat JS, Zonnenberg BA, Gebbink MF, Voest EE. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol 2004; 15: 139-145.
8. Zhang H, Vakil V, Braunstein M, Smith EL, Maroney J, Chen L et al. Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood 2005; 105: 3286-3294.
9. Rigolin GM, Fraulini C, Ciccone M, Mauro E, Bugli AM, De Angeli C et al. Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion. Blood 2006; 107: 2531-2535.
10. Fang B, Zheng C, Liao L, Han Q, Sun Z, Jiang X et al. Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics. Blood 2005; 105: 2733-2740.
11. Cazzola M, Malcovati L. Myelodysplastic syndromes - coping with ineffective hematopoiesis. N Engl J Med 2005; 352: 536-538.
12. Pellagatti A, Cazzola M, Giagounidis AA, Malcovati L, Della Porta MG, Killick S et al. Gene expression profiles of CD34+ cells in myelodysplastic syndromes: Involvement of interferon stimulated genes and correlation to FAB subtype and karyotype. Blood 2006; 108 337-345.
13. Rosenfeld C, List A. A hypothesis for the pathogenesis of myelodysplastic syndromes: Implications for new therapies. Leukemia 2000; 14: 2-8.
14. Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D et al Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96: 2240-2245.
15. Korkolopoulou P, Apostolidou E, Pavlopoulos PM, Kavantzas N, Vyniou N, Thymara I et al. Prognostic evaluation of the microvascular network in myelodysplastic syndromes. Leukemia 2001; 15: 1369-1376.
16. Cortelezzi A, Fracchiolla NS, Mazzeo LM, Silvestris I, Pomati M, Somalvico F et al. Endothelial precursors and mature endothelial cells are increased in the peripheral blood of myelodysplastic syndromes. Leuk Lymphoma 2005; 46: 1345-1351.
17. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292-2302.
18. Malcovati L, Della Porta MG, Pascutto C, Invernizzi R, Boni M, Travaglino E et al. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision making. J Clin Oncol 2005; 23: 7594-7603.
19. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079-2088.
20. Stelzer GT, Marti G, Hurley A, McCoy Jr P, Lovett EJ, Schwartz A. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Standardization and validation of laboratory procedures. Cytometry 1997; 30: 214-230.
21. Khan SS, Solomon MA, McCoy Jr JP. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 2005; 64: 1-8.
22. Bardin N, George F, Mutin M, Brisson C, Horschowski N, Frances V et al. S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue Antigens 1996; 48: 531-539.
23. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958.
24. Woywodt A, Blann AD, Kirsch T, Erdbruegger U, Banzet N, Haubitz M et al. Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: Proposal of a definition and a consensus protocol. J Thromb Haemost 2006; 4: 671-677.
25. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
26. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K et al Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104: 2752-2760.
27. Valgimigli M, Rigolin GM, Fucili A, Della Porta MG, Soukhomovskaia O, Malagutti P et al. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 2004; 110: 1209-1212.
28. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R et al Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005; 105: 199-206.
29. List A, Kurtin S, Roe DJ, Buresh A, Mahadevan D, Fuchs D et al. Efficacy of lenalidomide in myelodysplastic syndromes. N Engl J Med 2005; 352: 549-557.
30. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005; 106: 1525-1531.
31. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007; 109 1801-1809.
32. Ruiz de Almodovar C, Luttun A, Carmeliet P. An SDF-1 trap for myeloid cells stimulates angiogenesis. Cell 2006; 124: 18-21.
33. Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR et al Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007; 35: 1109-1118.
34. Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Vasculogenic mimicry and tumour-cell plasticity: Lessons from melanoma. Nat Rev Cancer 2003; 3: 411-421.
35. Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: The role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005; 112: 1618-1627.
36. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Jung S et al VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells. Cell 2006; 124: 175-189.
37. Okamoto R, Ueno M, Yamada Y, Takahashi N, Sano H, Suda T et al. Hematopoietic cells regulate the angiogenic switch during tumorigenesis. Blood 2005; 105: 2757-2763.